Funding for HIV, Hepatitis, STDs, Tuberculosis in U.S.-APIs

Key points

  • Accelerating the Prevention and Control of HIV, Viral Hepatitis, STDs, and TB in the U.S.-Affiliated Pacific Islands
  • Notice of Funding Opportunity (NOFO) Announcement: PS23-2302
  • 5-year cooperative agreement that builds on the previous PS13-1301 and PS18-1801 NOFOs

Funding overview

Flags of American Samoa, Guam, Palau, Federated States of Micronesia, Marshall Islands, American Mariana Islands.
Flags of U.S.-Affiliated Pacific Islands

This NOFO supports strategy to increase program collaboration and service integration (PCSI) of HIV, Viral Hepatitis, STD and Tuberculosis prevention through:

  • Enhanced engagement
  • Knowledge sharing
  • Integration across prevention and treatment services
  • Consolidated administrative processes

The NOFO will support recipients to:

  • Test, treat, and prevent infections in people with similar risk factors
  • Improve collection, reporting, use, and sharing of surveillance data
  • Develop public healthcare workforce through training and education
  • Strengthen laboratory quality management systems for reliable testing
  • Enhance prevention, care, and treatment activities for specific diseases

To achieve the long-term outcomes, applicants will be required to implement activities under five main strategies.

Program priorities

To achieve the long-term outcomes, applicants will be required to implement activities under five main strategies.

1. Program Collaboration and Service Integration (PCSI)

Outcome

Increased receipt of testing and treatment for multiple diseases as clinically indicated among patients

Activities

  • Implement integrated screening and testing in high priority settings
  • Integrate screening and testing of persons at risk for multiple diseases

2. Surveillance, Data Management, and Reporting

Outcomes

  • Increased complete and timely data reporting for USAPIs
  • Improved prevention programs and service delivery among disproportionately affected populations

Activities

  • Collect and manage surveillance and program data
  • Evaluate program effectiveness
  • Implement quality assurance processes
  • Use and disseminate data to drive public health action
  • Implement the current NCHHSTP Data Security and Confidentiality Guidelines

3. Workforce Development

Outcome

Increased public healthcare workforce skills to deliver prevention, screening, and care services for HIV, VH, STDs, and TB

Activities

  • Assign a focal point for the TB Education and Training Network
  • Build public healthcare workforce capacity
  • Participate in CDC-sponsored conferences and meetings
  • Develop and/or update policies and procedures to support program implementation across PCSI programs

4. Laboratory Strengthening

Outcomes

  • Improved availability of laboratory supplies within the expiration date
  • Improved availability of high-quality testing services
  • Decreased turnaround times for HIV, hepatitis B, STD, and TB testing

Activities

  • Deliver reliable, accurate, and timely public health laboratory services and ensure strong laboratory quality management systems
  • Evaluate laboratory data/practices and address needed improvements

5. Disease-Specific Prevention and Care

Outcomes

  • Increased awareness of HIV, hepatitis B, and STD or TB infection
  • Increased timely linkage to care for persons diagnosed with HIV, VH, STDs, and TB
  • Increased receipt of partner services and completion of contact investigations
  • Improved care outcomes for patients with diagnosed infection

Activities

  • Conduct or facilitate high impact prevention including: prevention, screening, testing, linkage to care, treatment, and case management
  • Provide partner services and contact investigation

Funding data

This program is supported by the Division of HIV Prevention, Division of Viral Hepatitis, Division of STD Prevention, and the Division of TB Elimination, in NCHHSTP at CDC.

In FY 2023, $3,900,000 million is anticipated to be awarded for Year 1 activities beginning January 2023, with up to six applicants expected to be funded. The total projected estimated funding for the entire 5-year project period is $19,500,000 million.

Additional resources

Contact: For Program Technical Assistance

Tamika Hoyte, Project Officer. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention

1600 Clifton Rd. MS E-07 Atlanta, GA 30333

Telephone: 404-639-6029 - Email: THoyte@cdc.gov

Contact: For Financial, Grants Management, or Budget Assistance

Edna Green, Grants Management Officer. Department of Health and Human Services, Centers for Disease Control and Prevention, Office of Grants Services

2920 Brandywine Rd., MS TV-2 Atlanta, GA 30341

Telephone: (770) 488-2858 - Email: EGreen@cdc.gov

Print
Content Source:
National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention